Background
==========

The bi-directional communications between the oocyte and its companion cumulus cells (CCs) is crucial for the development and functions of both cell types \[[@B1]-[@B3]\]. This dialogue is vital for the oocyte to acquire meiotic and developmental competence and for proliferation and differentiation of CCs \[[@B1],[@B3]-[@B9]\]. The oocyte regulates proliferation \[[@B2],[@B10]-[@B13]\], apoptosis \[[@B14]\], luteinization \[[@B13],[@B15]\], metabolism \[[@B16]\] and expansion \[[@B17],[@B18]\] of CCs through oocyte secreted factors (OSFs) such as growth and differentiation factor 9 (*GDF9*), bone morphogenetic protein 15 (*BMP15*) and possibly others. Competent oocytes also influence the expression of cumulus specific biochemical markers that might be crucial for cumulus expansion and thereby achieve maturation and successful development \[[@B17]-[@B19]\]. CCs play an important role in the utilization of energy substrates by oocyte \[[@B20]\], prevent the oocyte from oxidative stress induced apoptosis \[[@B21],[@B22]\] and stimulate glutathione synthesis \[[@B23],[@B24]\] during in vitro maturation. The ability of the oocyte to form male pronuclei after fertilization strongly depends on the presence of CCs during maturation \[[@B25]-[@B27]\] and fertilization \[[@B28]-[@B30]\]. Fertilization and development to a healthy blastocyst is limited by the oocyte quality \[[@B31]\] and CCs play a critical role in determining oocyte developmental potential both before and after ovulation \[[@B32]\].

The interaction between cumulus-granulosa cell derived factors such as kit ligand and oocyte secreted *GDF9*is essential for oocyte growth \[[@B33],[@B34]\]. This dialogue between the oocyte and CCs is accomplished mainly through the gap junction type of intercellular communication \[[@B35]\] and the presence of this junction supports oocyte competence in vitro \[[@B36]\]. For instance, complete removal of CCs before in vitro maturation or blockage of gap junction inhibits oocyte maturation \[[@B37]\]. Similarly, inhibition of these functional coupling using gap junction inhibitors significantly reduces developmental competence \[[@B38]\].

Developmentally competent oocytes are selected based on the number and compactness of the surrounding CCs layers \[[@B39],[@B40]\] as oocytes that fail to expand their CCs can\'t ovulate and/or are infertile \[[@B41]-[@B44]\]. There is notable species level difference regarding the source and identity of cumulus expansion enabling factor (CEEF). While OSFs, like *GDF9*and *BMP15*are believed to be CEEF in rat \[[@B45]\], their presence is not mandatory for bovine \[[@B46]\] and porcine \[[@B47]\] CCs expansion in vitro as oocytectomised complexes (CC - OO) expands as equally as the intact ones.

High expression of hyaluronan synthase 2 (*HAS2*), inhibin beta A (*INHβA*), epidermal growth factor receptor (*EGFR*), geremlin (*GREM1*), beta cellulin (*BTC*), cell cycle division 44 (*CD44*), tumor necrosis alpha induced protein 6 (*TNFAIP6*) and prostaglandin synthase 2 (*PTGS2*) have been associated with developmental competence of oocytes and suggested as predictors of embryo quality in women \[[@B40]\] and cow \[[@B48]\]. On the contrary, higher expressions of cysteine proteinases *cathepsin B*, *S*, *K*and *Z*have been associated with incompetent bovine oocytes \[[@B49]\].

Although studies were conducted to identify molecular biomarkers for developmentally competent bovine oocytes, large scale expression data on oocyte or CCs specific transcripts is still lacking. Removal of oocyte-CCs communication axis during in vitro maturation reduces CCs expansion and thereby affects oocyte developmental competence but the effect of removing this communication axis on their gene expression is poorly understood. Furthermore, genes differentially expressed between germinal vesicle (GV) and metaphase II (MII) stage CCs are not identified and functional changes associated with those differentially expressed genes are not characterized. Identification of transcripts that are exclusively and commonly expressed between the oocyte and its companion CCs and those that are affected when the oocyte and its companion CCs mature in the presence or absence of one or the other would enhance our understanding of the molecules and biological processes that are involved in oocyte-CCs dialogue and oocyte maturation.

Therefore, this study was conducted to 1. Identify transcripts that are co and exclusively expressed between the oocyte and CCs, 2. Enumerate those which are significantly affected when the two cell types mature with or without the other and 3. Identify significantly changed biological processes during the transition of CCs from GV to MII stage.

Methods
=======

Sample collection
-----------------

Bovine ovaries were collected from local abattoirs and transported to the laboratory within 2-3 hours (hrs) in a thermo flask containing 0.9% physiological saline solution at 39°C. Before aspiration of COCs, the ovaries were washed twice in 70% ethanol. COCs were aspirated from antral follicles having 2-8 mm diameter using 5 ml syringe attached to 18 gauge needle. The aspirated follicular fluid was collected in 50 ml sterilized tube at 35°C and allowed to precipitate for 15 min. COCs with evenly granulated cytoplasm surrounded by multiple layers of CCs were picked using glass-pipette and washed three times in drops of modified parker medium (MPM) supplemented with 12% estrus cow serum (OCS).

In order to increase the homogeneity of the experimental samples, COCs were further screened for developmental competence using brilliant cresyl blue (BCB) staining as described in \[[@B50]-[@B52]\]. BCB positive (BCB^+^) COCs were assigned randomly into the following four experiments. Each experiment had three pools of biological replicates; each replicate containing 50 oocytes or CCs samples (Figure [1](#F1){ref-type="fig"}). In experiment 1a, CCs were mechanically removed from oocytes at GV stage by repeated in and out pipetting and the resulting denuded oocytes (DOs), designated by number 1 and their companion CCs by number 2, were frozen. In experiment 1b, intact COCs were cultured; their companion CCs were mechanically removed and the resulting denuded MII oocytes, designated by number 4 and their companion CCs by number 3, were frozen. In experiment 2, CCs were mechanically removed from their enclosed oocytes at GV stage and the resulting (OO - CCs), designated by number 5 and other intact COCs (OO + CCs) were cultured separately. After 22 hr culture period, CCs were mechanically removed from the intact oocytes and the resulting denuded MII oocytes (number 6) were frozen. In experiment 3, oocytes were micro surgically removed from their companion CCs at GV stage as described previously \[[@B17],[@B46],[@B47]\]. Briefly, using micromanipulators with a holding pipette (20 pm diameter hole) and a fine glass needle, the complex is held under negative pressure and the oocyte pierced through both sides of the zona pellucida. The contents of the oocyte are then aspirated through the holding pipette while removing the glass needle, resulting in temporary deformation of the zona pellucida. Almost all of the oocyte contents are removed in this way, leaving an intact complex without the oocyte, the oocytectomised complex (CCs - OO). The resulting complexes (CCs - OO), designated by number 7 and other intact complexes (CCs + OO) were cultured. After 22 hr culture, oocytes were micro surgically removed from their intact cumulus oocyte complexes (CCs + OO), as described above and the resulting MII CCs without their enclosed oocytes, designated by number 8 were frozen. In experiment 4, CCs were mechanically removed from their enclosed oocytes both at GV (number 9) and MII stages (number 10) and frozen for subsequent total RNA isolation. In both cases, cells were cultured for 22 hrs and each experiment was repeated three times. Complete removal of either cell from one or the other was confirmed by microscopic examination of the corresponding samples (Figures [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}) as described in \[[@B53]\]. Cells were cultured in groups of 50 in 400 μl MPM medium supplemented with 12% estrus cow serum and 10 μg mL^-1^FSH for 22 hr at 39°C in an incubator with humidified atmosphere containing 5% CO~2~. Samples were stored at -80°C until subsequent RNA isolation.

![**Diagrammatic illustration of the experimental design showing groups that were used for total RNA isolation, cDNA synthesis, array hybridization and quantitative and semi-quantitative RT-PCR validation of the array data**. Numbers, 1 - 10, under each oocyte and CCs figure, represent the samples that were used for RNA isolation, cDNA synthesis and array hybridisation, as explained in materials and methods section. For all experimental groups, the samples were derived from GV stage COCs.](1471-2164-12-57-1){#F1}

![**Representative images showing CCs from which the enclosed oocyte was completely removed at GV stage using oocytectomy (A) and the oocyte from which the companion CCs were completely removed mechanically at GV stage using pipettes (B) and intact COC (C)**. Images were taken using Leica DM-IRB microscope with a magnification of 100×.](1471-2164-12-57-2){#F2}

RNA isolation and array processing
----------------------------------

In all experiments, always triplicate pools of oocytes or their corresponding CCs (each pool contains 50 oocytes or their corresponding CCs), were used for RNA isolation and subsequent downstream analysis. The total oocytes or CCs samples used for this study correspond to 150 oocytes or their respective CCs per each experiment.

Total RNA was isolated using PicoPure RNA Isolation Kit according to the manufacturer\'s instruction (Arcturus Bioscience Mt. View CA). Briefly, the samples were extracted using 100 μL of extraction buffer and resuspended by pipetting gently. They were incubated for 30 min at 42°C and centrifuged at 3,000 × *g*for two min. One hundred μL of 70% ethanol was pipetted to the cell extract and mixed well by pipetting up and down. Two hundred μL conditioning buffer was pipetted onto the purification column filter membrane and the columns were incubated with conditioning buffer for 5 min at room temperature. The purification columns were centrifuged in the provided collection tube at 16,000 × *g*for 1 min and 50 μL of 70% ethanol was pipetted into the cell extract. The cell extract and ethanol mixture were pipetted into the preconditioned purification column. RNA was bound to the column by centrifuging for 2 min at 100 × *g*, immediately followed by a centrifugation at 16,000 × *g*for 30 sec to remove flow through. One hundred μL wash buffer 1 was pipetted into the purification column and centrifuged for 1 minute at 8,000 × *g*. Contaminating DNA was removed by DNase treatment. One hundred μL of wash buffer 2 (W2) was pipetted into the purification column and centrifuged for 1 min at 8,000 × *g*. Another 100 μL W2 was pipetted into the purification column and centrifuged for 2 min at 16,000 × *g*. The purification column was checked for any residual wash buffer by re-centrifuging at 16,000 × *g*for 1 min and transferred to a new 0.5 mL micro centrifuge tube provided in the kit. Eleven μL of elution buffer was pipetted directly onto the membrane of the purification column and finally, the isolated total RNA was preserved in the elution buffer and used for down stream applications.

RNA quality and yield of each sample were determined using Bioanalyzer 2100 and RNA 6000 Pico LabChip assay (Agilent Technologies Inc, Palo Alto, CA) in combination with Quant-iT™ RiboGreen Reagent according to supplied protocols (Invitrogen, Carlsbad, CA). Initial total RNA concentration across all samples were adjusted to the lowly concentrated sample (12 ng) and this amount of total RNA were used for the two round cDNA synthesis and subsequent in vitro-transcription according to the two-cycle eukaryotic target labeling assay (Affymetrix expression analysis technical manual: Eukaryotic sample and array processing <http://www.affymetrix.com/support/technical/manual/>. MEGA script in vitro transcription kit containing T7-Oligo (dT) primer and other components (MEGAscript^®^high yield transcription kit, Applied Biosystems, Ambions) and random primers (Invitrogen, Karlsruhe, Germany) were used for the first and second cycle of cDNA synthesis. Fifteen μg of fragmented and biotin-labeled complementary RNA (cRNA) of each group were hybridized with Affymetrix bovine Genome 430 v2.0 GeneChip^®^arrays for 16 hrs at 45°C. Post-hybridization staining and washing were performed according to manufacturer\'s protocols using the Fluidics Station 450 instrument.

Image capturing, quantification and data analysis
-------------------------------------------------

Array slides were scanned with a GeneChip™ 3000 laser confocal slide scanner (Affymetrix) and the images were quantified using Gene Chip Operating Software (GCOS, Affymetrix) version 1.2. Probe level data were imported into the R software environment <http://www.r-project.org>. Data normalization and background correction were performed using guanine-cytosine Robust Multichip Average (gcRMA) function as described in \[[@B54]\]. gcRMA adjusts for background intensities in Affymetrix array data which include optical noise and non-specific binding (NSB). The main function gcRMA converts background adjusted probe intensities to expression measures using the same normalization and summarization methods as RMA (Robust Multiarray Average). It uses probe sequence information to estimate probe affinity to non-specific binding (NSB). The sequence information is summarized in a more complex way than the simple GC content. Instead, the base types (A,T,G or C) at each position (1-25) along the probe determine the affinity of each probe. The parameters of the position specific base contributions to the probe affinity are estimated in an NSB experiment in which only NSB but no gene-specific binding is expected.

The presence or absence of genes were detected using microarray suit 5 (MAS 5, Affymetrix) as described in \[[@B42],[@B55]\]. To minimize false positive signals, genes called absent were avoided and these called present in at least two of the three replicates were used for further analysis. Differential gene expression was analyzed using linear models for microarray (LIMMA) as described in \[[@B56]\]. LIMMA is a package for differential expression analysis of data arising from microarray experiments. The package is designed to analyze complex experiments involving comparisons between many RNA targets simultaneously while remaining reasonably easy to use for simple experiments. The central idea is to fit a linear model to the expression data for each gene. The expression data can be log-ratios, or sometimes log-intensities, from two colour microarrays or log-intensity values from one channel technologies such as Affymetrix. The MIAME guidelines with details of sample preparation, experimental design, array processing and hybridization, measurements and normalisation controls are given in additional file [1](#S1){ref-type="supplementary-material"}.

Differentially expressed genes in experiments 1A and B were classified according to their gene ontology (GO) using GO consortium \[[@B57]\] and lists of genes over expressed in OO + CCs and CCs + OO relative to those expressed in OO - CCs and CCs - OO respectively, were uploaded into Ingenuity Pathways Analysis (IPA), (Ingenuity Systems, <http://www.ingenuity.com>) to identify relationships between the genes of interest and to uncover common processes and pathways in the positive phenotypes. IPA is a web-based software application that enables the modelling and analysis of biological systems using microarray data.

Validation of the microarray data using semi quantitative and quantitative real time RT-PCR
-------------------------------------------------------------------------------------------

Array data was validated using real time quantitative reverse transcription PCR (qRT-PCR). For this, additional pools of biological replicates representing independent oocytes and CCs samples (n = 150) were used for total RNA isolation and cDNA synthesis. In order to reduce the variability in the concentration of the initial RNA populations across samples and to use

equivalent RNA quantities to the ones used for array hybridization, 12 ng of the total RNA of each sample was used for cDNA synthesis using oligo (dt)25 and random primer as described elsewhere \[[@B58]\]. The ABI prism^®^7000 apparatus (Applied Biosystems) was used to perform the quantitative analysis using SYBR^®^Green Jumpstart™ Tag Ready Mix™ (Sigma) incorporation for dsDNA specific fluorescent detection dye. Standard curves were fitted for both target genes and internal control (18S rRNA) using serial dilutions of plasmid DNAs containing 10^1^-10^9^molecules and run in separate wells. PCR was assembled using 20 μl total reaction volume containing double distilled (dd) water, forward and reverse primers, SYBR green universal master mix (Sigma) and 2 μl template cDNAs using five replicates for each sample. During each reaction, samples from the same cDNA were run in duplicate to control the reproducibility of the results. A universal thermal cycling parameter (initial denaturizing step at 95°C for 3 min, 45 cycles of denaturizing at 95°C for 30 sec and 58°C for 30 sec were used to quantify mRNA expression level. After the end of the last cycle, dissociation curves were fitted by starting the fluorescence acquisition at 60°C and taking measurements every 7 sec interval until the temperature reaches 95°C. Final quantitative analysis was done using relative standard curve method and the expression values of the target transcripts were normalized to that of 18S. The mean normalized data were reported as the amount of a given target gene transcript in the two samples compared and significantly different means were identified using t-test (SPSS Inc. Chicago, IL, USA). Pairs of primers that were used for array validation are shown in Table [1](#T1){ref-type="table"}.

###### 

Pairs of primers that were used for validation of array data

  Gene name   Accession number               Forward (5\' - 3\')      Reverse (3\' - 5\')      Annealing temperature (°C)   Product length (bp)
  ----------- ------------------------------ ------------------------ ------------------------ ---------------------------- ---------------------
  GDF9        [NM_174681](NM_174681)         AGCGCCCTCACTGCTTCTATAT   ACACCCTCAGCAGCTTCTTCTC   57                           152
  MSX1        [NM_174798](NM_174798)         AAGGTATCCACAGTCCCCAGC    TCTGCCTCTCCTGCAAAGTTC    56                           180
  IRF6        [NM_001076934](NM_001076934)   GGACTCCAAACGCTTCCAGA     TCCTTGGTGCCATCATACATCA   54                           212
  SPARC       [NM_174464](NM_174464)         CGATGATGGTGCTGAGGAAA     TGGTGGCAAAGAAGTGGCA      53                           220
  HPSE        [NM_1744082](NM_1744082)       ATGGGCATAGAAGTGGTGATGA   TGTTTGGTGTTTGTGCAATGAA   TD 54-50                     202
  DGAT2       [NM_205793](NM_205793)         TGAACCGGGACACCATAGACTA   CACCTCATTCTCCCCAAAGGA    55                           205
  SOX2        [NM_001105463](NM_001105463)   GCGGCAACCAGAAGAACAG      GCTTCTCCGTCTCGGACAAA     55                           170
  HAS2        [NM_174079](NM_174079)         CCAAATGAAATGCCAAAGGAA    CAACGTCAACCAAGCTTCACA    TD 54-50                     237
  PTX3        [NM_001076259](NM_001076259)   TTTATTCCCCATGCGTTCCA     CTCCACCCACCACAAGCATT     53                           205
  IGF2BP3     [XM_588560](XM_588560)         GACGCGAAAGTGAGGATGGT     TGCACTTGACAAATTCTGGAGC   54                           215
  ADAMTS1     [NM_001101080](NM_001101080)   TCGTCATACAGCTCCCCTCC     ATTGACACACCATTTCCCCTCT   TD 57-54                     220
  PDK4        [XM_583960](XM_583960)         ATTTTTGCGACAAGAGTTGCCT   GGATTCCTTGTGCCATTGTAGG   TD 56-52                     250
  CCRK        [XM_879150](XM_879150)         GGCCCCACTCATGGCTACTT     TCCTGAGGGTGATGCTGGTAA    57                           170
  FOSB        [XM_880646](XM_880646)         TTCCTGAATCTCTCCCGCC      TGCTCACAGCCTCACACTCG     56                           205
  POU5F1      [NM_174580](NM_174580)         AGAAGGGCAAACGATCAAGC     GGTGACAGACACCGAGGGAA     TD 57-53                     205
  VEGFA       [NM_174216](NM_174216)         GGTTTCGGGAACCAGACGT      GGCAATCCAATTCCAAGAGGA    55                           233
  18S         [NR_003286](NR_003286)         GTGCCCTTCCGTCAATTCCT     ACGAAAGTCGGAGGTTCGAA     55                           184
  GPT         [XM_585516](XM_585516)         CCGATGAGGTGTACCAAGACAA   CCATATTCACCACCTCCACGT    55                           185
  DAPL1       [NM_001025346](NM_001025346)   AAATTTCCAGCAGTAGCGCAC    AGCTCTCAGACATTCGAGGCA    55                           158
  IRF7        [NM_001105040](NM_001105040)   CTCCCCGCACTACACCATCTA    GCCTGTTCCACCTCCATCA      TD 58-55                     245
  GADD45A     [NM_001034247](NM_001034247)   GACCGAAAGGATGGATAAGGTG   TGGATCAGGGTGAAGTGGATCT   56                           200
  DPP4        [NM_174039](NM_174039)         CAACTGGGCTACTTACCTTGCA   TTACGTACCCTCCGTATGACCA   56                           223
  IFI6        [NM_001075588](NM_001075588)   ACGGTGACAAAGCCTTGAGC     AGGTCACCATGCCCCAGAA      55                           158
  ADAMTS4     [NM_181667](NM_181667)         CCATTGTGGAGGATGATGGG     AGGAAGTCAGTGATGAAGCGG    55                           210
  CASP1       [XM_592026](XM_592026)         CTCACTCAGAGCATCGGACCT    GTTTACCCATACCATCCCTTGC   57                           229
  IFIT5       [NM_001075698](NM_001075698)   CACAGTGTATCGGCTGGATGA    GGTTGGGCTGATATCTGGTCC    56                           200
  DDX39       [NM_001034752](NM_001034752)   GCAGTTCAAGGACTTCCAGC     GCTCTGCCACATTCACTTCA     TD 55-52                     228
  GTF2A2      [NM_001037619](NM_001037619)   AGAAAGAGGTTCTGCCCGGA     CTTATCGGCTGCATTGAAAGC    55                           150
  TSSC1       [XM_001789233](XM_001789233)   AGCAGCGACAGCAGAGTCATC    TAGCTCAGGGAGGCGAACAG     57                           229
  FSHR        [NM_174061](NM_174061)         GCTGGATCTTTGCTTTTGCAGT   ATGCGCTTGGCTATCTTGGT     54                           243
  GPT         [NM_001083740](NM_001083740)   CCGATGAGGTGTACCAAGACAA   CCATATTCACCACCTCCACGT    56                           185
  PLAUR       [NM_174423](NM_174423)         GGATTCCACAACAACCACACCT   TCGCTTCCAGACATTGATTCAT   TD 56-52                     204
  CA2         [NM_178572](NM_178572)         CAAAGCAGTGCTGAAAGATGGA   AAAACACCCACAACAGCCAGTC   55                           212

Touch down (TD) = The forward and the reverse primers of a given gene have different annealing temperatures

The appropriateness of 18S as internal control was confirmed by the results of semi-quantitative RT-PCR showing its stability across all samples.

Immunofluorescence staining
---------------------------

In order to localize the proteins of some differentially expressed transcripts, ovarian sections were washed three times in PBS and fixed in 4% (w/v) Paraformaldehyde overnight at 4°C. The fixed specimens were permeabilized during 2.5 hr incubation in 0.5% (v/v) Triton-X100 (Sigma) in PBS. To inhibit NSB of the antibodies, samples were subsequently blocked in 3% (w/v) bovine serum albumin (BSA) in PBS for 1 hr. The sections were then incubated for 1 hr at 39°C and mounted onto glass slides with gelvatol. The primary antibody for IRF6 (rabbit anti-human polyclonal antibody, Santa Cruz Biotechnologies Inc., Germany) was used at 1:100 in PBS and for MSX1 (rabbit anti-human polyclonal antibody, Lifespan Biosciences, USA) at 1:50 in blocking solution. The samples were incubated for 15 and 1 hr with primary and secondary antibodies (FITC conjugated goat anti-rabbit secondary antibody (Lifespan Biosciences, USA), respectively using 1:100 ratio in both cases. Negative controls were processed in the same manner by omitting the use of primary antibody. In order to visualize the nucleus, the sections were finally incubated in 0.1 mg/ml 4\'-6-Diamidino-2-phenylindole (DAPI, Sigma) or propidium iodide (Sigma). After the final wash in PBS, the sections were mounted on glass slides and visualized on ApoTome microscope (ApoTome MicroImaging, Inc., Carl-Zeiss, Germany).

Results
=======

Specific transcription programs are exhibited by bovine oocytes and CCs
-----------------------------------------------------------------------

In order to get an insight into specific transcription program in bovine oocytes and CCs, we analyzed transcriptome profile of GV (number 1) and MII (number 4 ) oocytes and their companion CCs (number 2 and 3, respectively) using MAS 5 present or absent call as described elsewhere \[[@B42],[@B59]\]. The raw data from all arrays are available online at <http://www.ncbi.nlm.nih.gov/geo/> with GEO accession number GSE21005. The analysis showed that of 13162 detected genes, 1516 and 2727 are exclusively expressed in GV oocytes (number 1) and their companion CCs (number 2), respectively while 8919 are expressed in both (Additional files, [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"} and [4](#S4){ref-type="supplementary-material"}). Similarly, of 13602 detected genes, 1423 and 3100 are expressed exclusively in MII oocytes (number 4) and their companion CCs (number 3), respectively and 9079 are expressed in both (Additional files, [5](#S5){ref-type="supplementary-material"}, [6](#S6){ref-type="supplementary-material"} and [7](#S7){ref-type="supplementary-material"}). In addition, expression analysis of these detected genes showed that a total of 8612 transcripts are differentially expressed between GV oocytes (number 1) and CCs (number 2) of which 4304 and 4308 are over expressed in oocytes and CCs, respectively (Additional file [8](#S8){ref-type="supplementary-material"}). Similarly, a total of 8863 transcripts are differentially expressed between MII oocytes (number 4 ) and CCs (number 3) of which 4271 and 4592 were over expressed in MII oocytes and CCs, respectively (Additional file, [9](#S9){ref-type="supplementary-material"}). The heat map and hierarchical clustering of some of the top differentially expressed genes between oocytes and CCs at the two stages are presented in Figures [3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"} and [4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}.

![**Hierarchical clustering and heat map of some of the top genes over expressed in GV oocytes (A) and CCs (B) with a fold change of more than 1024**. Abbreviations, GVOO and GVCCs stand for germinal vesicle oocyte and cumulus cells, respectively. Numbers (1, 2, and 3) indicate the three biological replicates used for microarray hybridization.](1471-2164-12-57-3){#F3}

![**Hierarchical clustering and heat map of some of the top over expressed genes in MII oocytes (A) and CCs (B) with a fold change of more than 512**. Abbreviations, MIIOO and MIICCs stand for metaphase II oocyte and cumulus cells, respectively. Numbers (1, 2, and 3) indicate the three biological replicates used for microarray hybridization.](1471-2164-12-57-4){#F4}

The GO categories (biological and molecular functions) of transcripts over expressed in GV oocytes and CCs relative to each other are shown in Figure [5](#F5){ref-type="fig"} and additional file [10](#S10){ref-type="supplementary-material"}, respectively. The most significantly changed molecular and cellular functions associated with genes over expressed in MII CCs relative to their enclosed oocytes and vice versa are also shown in additional file [11](#S11){ref-type="supplementary-material"}.

![**The top significantly changed GO terms (biological processes) with the proportion of transcripts involved among those over expressed in GV oocytes and CCs**. The proportion of transcripts in a GO term was calculated as the number of genes over expressed in one sample divided by the total number of genes that are involved in that given GO term multiplied by 100 (P \< 0.001).](1471-2164-12-57-5){#F5}

Removal of oocyte or CCs at GV alters the gene expression of either cell at MII stage
-------------------------------------------------------------------------------------

In order to investigate transcriptome profile changes when the oocyte matures with or without its companion CCs and when CCs mature with or without their enclosed oocytes, we analyzed their corresponding transcriptome profiles using LIMMA as described previously \[[@B56]\]. The analysis showed that a total of 265 genes are differentially expressed between OO + CCs (number 5) and OO-CCs (number 6) of which 217 and 48 are over expressed in OO + CCs and OO - CCs, respectively (Additional file [12](#S12){ref-type="supplementary-material"}).

Similarly, 566 genes are differentially expressed between CCs that were cultured with (CCs + OO) (number 7) or without their enclosed oocytes (CCs - OO) (number 8) of which 320 and 246 are over expressed in CCs + OO and CCs - OO, respectively (Additional file [13](#S13){ref-type="supplementary-material"}). Hierarchical clustering and heat map of the top differentially expressed genes between OO + CCs and OO - CCs and between CCs + OO and CCs - OO, with a fold change of \> 4 and 16, are presented in Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}, respectively.

![**Hierarchical clustering and heat map of the top differentially expressed genes between oocytes cultured with (red bar) or without (green bar) their companion CCs with a fold change of more than 4**. Abbreviations, OO + CCs and OO - CCs stand for oocytes cultured with or without their companion CCs, respectively and numbers (1, 2 and 3) indicate the three biological replicates that were used for microarray hybridization.](1471-2164-12-57-6){#F6}

![**Hierarchical clustering and heat map of the top differentially expressed genes between CCs cultured with (red bar) or without (green bar) their enclosed oocytes with a fold change of more than 16**. Abbreviations, CCs + OO and CCs - OO stand for cumulus cells cultured with or without ooplasm, respectively. Numbers (1, 2 and 3) indicate the three biological replicates that were used for microarray hybridization.](1471-2164-12-57-7){#F7}

We found that 36 and 375 of these genes over expressed in OO + CCs and CCs + OO, respectively, could be assigned to a specific functional group based on the information in the IPA Knowledge Base. Only 4 of the mapped genes over expressed in OO + CCs group, representing about 1.5% of the total, are classified under the functional group \"Carbohydrate metabolism,\" which contains genes involved in energy conversion and modulation. Other functional groups, including molecular transport, nucleic acid metabolism, small molecule biochemistry and RNA post transcriptional modification are also observed. Similarly, 90 of the genes over expressed in CCs + OO, representing 34% of the total are classified under cellular growth and proliferation. A graphical representation of this functional classification of the genes over expressed in OO + CCs and CCs + OO are shown in Figures [8](#F8){ref-type="fig"} and [9](#F9){ref-type="fig"}, in which 16 and 12 functional groups with higher *P*-values are noted. Some of these groups shared several common genes. In addition, 28 and 23 of the genes over expressed in OO + CCs and CCs + OO relative to OO - CCs and CCs - OO respectively, are assigned to 5 and 8 different canonical pathways (Additional files [14](#S14){ref-type="supplementary-material"} and [15](#S15){ref-type="supplementary-material"}). Finally, these genes from the two groups were mapped on 5 top networks each network containing genes from the input data that shared known direct or indirect relationships. Examples of networks created from our data are shown in Figures [10](#F10){ref-type="fig"} and [11](#F11){ref-type="fig"}, where the relationships between molecules that were over expressed in OO + CCs and CCs + OO are represented by the arrows that connect them. Figure [10](#F10){ref-type="fig"} shows a complex network that plays an important role in gene expression, small molecule biochemistry and carbohydrate metabolism while Figure [11](#F11){ref-type="fig"} shows a network that plays a role in cellular development.

![**Functional grouping of genes that are over expressed in the OO + CCs relative to OO - CCs samples showing the most significant functional groups, with P values, 0.05**. The bars represent the P-value in logarithmic scale for each functional group.](1471-2164-12-57-8){#F8}

![**Functional grouping of genes that are over expressed in the CCs + OO relative to CCs - OO samples showing the most significant functional groups, with P values, 0.05**. The bars represent the P-value in logarithmic scale for each functional group.](1471-2164-12-57-9){#F9}

![**An example of a gene network, showing the relationships between molecules identified by the microarray and over expressed in oocytes cultured with their companion CCs**. The type of the association between two molecules is shown as a letter on the line that connects them. The number in parenthesis next to the letter represents the number of bibliographic references currently available in the Ingenuity Pathways Knowledge Base that support each one of the relationships. Direct or indirect relationships between molecules are indicated by solid or dashed lines connecting them, respectively. P = phosphorylation, A = gene activation, E = increase in expression, PP = protein-protein interaction, PD = protein-DNA binding, MB = membership in complex, LO = localization, L = proteolysis, RB = regulation of binding](1471-2164-12-57-10){#F10}

![**An example of a gene network, showing the relationships between molecules identified by the microarray and over expressed in CCs cultured with the enclosed oocytes relative to those cultured without**. The type of the association between two molecules is shown as a letter on the line that connects them. The number in parenthesis next to the letter represents the number of bibliographic references currently available in the Ingenuity Pathways Knowledge Base that support each one of the relationships. Direct or indirect relationships between molecules are indicated by solid or dashed connecting lines, respectively. P = phosphorylation, A = gene activation, E = increase in expression, PP = protein-protein interaction, PD = protein-DNA binding, MB = membership in complex, LO = localization, L = proteolysis, RB = regulation of binding](1471-2164-12-57-11){#F11}

Global transcriptome changes in the CCs and associated functional changes during COCs in vitro maturation
---------------------------------------------------------------------------------------------------------

In this experiment we analyzed global transcriptome changes during the transition of CCs from GV (number 9) to MII (number 10) stage. The results of MAS 5 present and absent call showed that of 12827 detected genes 4689 and 834 are exclusively expressed in GV and MII CCs, respectively, while 7304 are expressed commonly at both stages (Additional files, [16](#S16){ref-type="supplementary-material"}, [17](#S17){ref-type="supplementary-material"} and [18](#S18){ref-type="supplementary-material"}). Additionally, expression analysis of these detected genes showed that a total of 4677 genes are differentially expressed between the two samples of which 2397 and 2280 are over expressed in GV and MII stages, respectively (Additional file [19](#S19){ref-type="supplementary-material"}). The heat map and hierarchical clustering of the top differentially expressed genes (fold change \> 256), GO categories (biological processes and cellular and molecular functions) between the two CCs stages are shown in Figures [12](#F12){ref-type="fig"}, [13](#F13){ref-type="fig"} and [14](#F14){ref-type="fig"}, respectively.

![**Hierarchical clustering and heat map of some of the top differentially expressed genes between GVCCs (A) and MIICCs (B) with a fold change of more than 256**. Abbreviations, GVCCs and MIICCs stand for germinal vesicle and metaphase II CCs respectively. Numbers (1, 2 and 3) indicate the three biological replicates that were used for microarray hybridization.](1471-2164-12-57-12){#F12}

![**The top significantly changed GO terms (biological processes) with the proportion of transcripts involved among these over expressed in GV and MIICCs relative to each other**. The proportion of transcripts in a GO term was calculated as the number of genes over expressed in one sample divided by the total number of genes that are involved in that given GO term multiplied by 100 (P \< 0.001).](1471-2164-12-57-13){#F13}

![**The top significantly changed GO terms (cellular and molecular functions) with the proportion of transcripts involved among these over expressed in GV and MII CCs relative to each other**. The proportion of transcripts in a GO term was calculated as the number of genes over expressed in one sample divided by the total number of genes that are involved in that given GO term multiplied by 100 (P \< 0.001).](1471-2164-12-57-14){#F14}

Validation of the microarray data using quantitative and semi quantitative real time RT-PCR
-------------------------------------------------------------------------------------------

In order to validate the micro array data, a total of 23 transcripts were quantified using qRT-PCR as described in materials and methods section. The assayed genes are selected based on the criteria of being abundant at significantly higher level or their exclusive abundance in either of the samples considered in the array analysis. Transcripts Semi-quantitative RT-PCR was also adopted to validate some genes that are exclusively expressed either as the oocyte or CC transcripts. With the exception of one transcript, the results of qRT-PCR analysis validated the array data as the expression levels of a given transcript between the two samples compared (designated by \*) are significantly different (P \< 0.05) (Figures [15](#F15){ref-type="fig"}, [16](#F16){ref-type="fig"}, [17](#F17){ref-type="fig"}, [18](#F18){ref-type="fig"}, [19](#F19){ref-type="fig"}). Additionally, semi-quantitative RT-PCR validation of some selected genes also supports the microarray data (Figure [20](#F20){ref-type="fig"}). The actual microarray expression values of genes validated using real time qRT-PCR analysis are shown as additional files [20](#S20){ref-type="supplementary-material"}, [21](#S21){ref-type="supplementary-material"}, [22](#S22){ref-type="supplementary-material"}, [23](#S23){ref-type="supplementary-material"} and [24](#S24){ref-type="supplementary-material"}.

![**qRT-PCR validation of the array data showing some selected transcripts that are differentially expressed between GV stage oocytes and CCs**. Two bars representing the same gene and marked with star (\*) between them are significantly different (P \< 0.05). OOIM = immature (GV) stage oocytes and CCIM = immature (GV) stage CCs.](1471-2164-12-57-15){#F15}

![**qRT-PCR validation of the array data showing some selected transcripts that are differentially expressed between MII oocytes and CCs**. Two bars representing the same gene and marked with star (\*) between them are significantly different (P \< 0.05). OOMII = metaphase II oocytes and CCMII = metaphase II CCs.](1471-2164-12-57-16){#F16}

![**qRT-PCR validation of the array data showing some selected transcripts that are over expressed in oocytes cultured with their companion CCs compared with those cultured alone**. Two bars representing the same gene and marked with star (\*) between them are significantly different (P \< 0.05). OO + CC = oocytes cultured with CCs and OO - CC = oocytes cultured without CCs.](1471-2164-12-57-17){#F17}

![**qRT-PCR validation of the array data showing some selected transcripts that are over expressed in CCs cultured with their enclosed oocytes compared with those cultured alone**. Two bars representing the same gene and marked with star (\*) between them are significantly different (P \< 0.05). CC + OO = CCs cultured with their enclosed oocyte and CC - OO: CCs cultured without oocyte.](1471-2164-12-57-18){#F18}

![**qRT-PCR validation of the array data showing some selected transcripts that are differentially expressed between GV and MII CCs**. Two bars representing the same gene and marked with star (\*) between them are significantly different (P \< 0.05). CCIM = immature or GV stage CCs and CCMII = cultured or metaphase II CCs.](1471-2164-12-57-19){#F19}

![**Validation of the microarray data by semi quantitative RT-PCR. A 2% agarose gel electrophoresis depicting the mRNA expression of genes that are exclusively expressed either in oocytes or CCs**. Number 1 shows a negative control (dd water as a template) and 2, 3, 4 and 5 show the abundance levels of each transcript in MII CCs, MII oocytes, GV CCs and GV oocytes, respectively. 18S was used as a loading control for total RNA.](1471-2164-12-57-20){#F20}

Immunoflourescence staining for localization of two selected proteins, IRF6 and MSX1, in oocyte or CCs clearly demonstrated that IRF6 is expressed only in oocyte and MSX1 is expressed in both oocyte and CCs showing the accuracy of our hybridization protocol (Figure [21](#F21){ref-type="fig"}).

![**Immunoflourescence images taken from sections of ovarian follicles showing the protein of IRF6 expressed only in oocytes and that of MSX1 expressed in both oocyte and CCs**. Lanes A and E. = ovarian sections incubated with IRF6 and MSX1 primary antibodies showing the location of IRF6 and MSX1 proteins, respectively. B and F = Protein and nuclear staining showing IRF6 and MSX1 proteins and DNAs together. C = Sections incubated only with DAPI showing the nucleus of the cells D. Negative control staining in which the sections were incubated only with secondary antibodies. The red arrows indicate the location of each protein. Scale bars below each picture represent 20 μm](1471-2164-12-57-21){#F21}

Discussion
==========

We analyzed the transcriptome profiles of bovine oocytes and their companion CCs and investigated transcriptome profile changes when either cell type matures with or without the other using Affymetrix GeneChip Bovine Genome Array. Here, we identified for the first time, transcripts that are exclusively expressed in bovine oocytes or CCs at GV and MII stages. Identifying specific transcription programs either in oocyte or CCs has a paramount importance in RNAi based gene function study. Knowledge of genes exclusively expressed either in oocyte or CCs would enable researchers to select the appropriate design for functional analysis of genes and route of introducing RNAi agents into COC. For instance, if a given gene is expressed only in CCs, transfection is the best method of introducing anti-sense oligomers into the complex. Identification of such genes would help also in understanding functional biological processes and pathways specific to either oocyte or CCs.

Additionally, we assessed the effect of removing the bi-directional communication axis on the gene expression profile of either cell during in vitro maturation and transcriptome profile changes associated with the transition of CCs from GV to MII stage at global scale. Identification of genes that are significantly affected when either the oocyte or CCs mature with or without one or the other would be vital to understand the most important cellular and molecular functions that are associated with the acquisition of developmental competence.

Specific expression program is exhibited by bovine oocyte and CCs
-----------------------------------------------------------------

In addition to the previously identified ones \[[@B42],[@B59]\], this study identified several oocyte or CCs specific transcripts that may play important biological roles in the bi-directional communication of the two cell types during in vitro maturation and for the acquisition of developmental competence at latter stages. Hierarchical clustering of differentially expressed genes demonstrated that the expression profile of oocyte is markedly different from that of its companion CCs with the latter having more number of transcripts than the former.

Transcripts that are over expressed in oocytes are involved in processes leading to meiotic maturation. We found considerably higher (more than 1024 fold change) and exclusive expression of *GDF9, BMP15, MOS*, Zona Ppellucida Proteins (*ZP2, 3, 4*), *NLRP5, RBM35A*, *TACSTD1, GAS7*and others in oocyte compared with CCs. Since the roles of *GDF9*and *BMP15*in oocyte growth and maturation have been widely addressed \[[@B2],[@B60],[@B61]\] we are not going to discuss them here. The *c-mos*proto-oncogene product *MOS*is believed to be an active component of the cytostatic factor that stabilizes and sustains the activity of maturation-promoting factor (MPF). Notable interspecies differences exist among different vertebrates regarding the physiological effects of *MOS*on oocyte maturation. Its higher expression in oocytes both at GV and MII stages in the current study supports previous claims that MOS is required both for the activation of MPF during meiosis I and II and for the meiotic arrest at meiotic MII \[[@B62],[@B63]\].

Trans-membrane proteins are involved in oocyte-granulosa cell regulatory loop and Rho proteins play a role in GTP-bound active state and can interact with a number of effectors to transduce signals leading to diverse biological responses including actin cytoskeletal rearrangements, regulation of gene transcriptions, cell cycle regulation, control of apoptosis and membrane trafficking \[[@B64],[@B65]\]. Phosphorylation and dephosphorylation of proteins are also crucial and control nearly every cellular activities, including metabolism, transcription and translation, cell-cycle progression, cytoskeletal rearrangement, protein-protein interactions, protein stability, cell movement, and apoptosis. These processes in turn depend on the highly regulated and opposing actions of protein kinases (PKs) and phosphatases (PPs) where the balance between the two plays an important role in the control of oocyte meiotic resumption \[[@B66]\]. Consistent with this notion, we found oocyte specific expression of many of the members of trans-membrane proteins (*TMEM30B, TMEM163, TMEM32, TMEM120B*and *TMEM52*) and Rho GTPase activating proteins (*ARHGAP10, 17, 18, 22, 24, 26, 27, 28*), various members of the mitogene activated protein kinases (*MAP4K2, MAPK10, MAPK8IP2*), and phosphatases (*PPP1R1B, PPP2R2B, PPP3R1, PPP1R3D*) that may evidence the roles of these genes in meiotic maturation.

Like wise, some of the transcripts that were highly expressed in CCs relative to oocyte include *IFIT5, BMP2, FSHr, GSTA1, FST, PTGR1*, hormonal receptors and hormones such as *INHA, INHBA, PGR*and *PGRMC2*. The oocyte and CC genes expression study has revealed that the receptor of *BMP2*, also a receptor for *GDF9*, is expressed only in CCs \[[@B42]\]. Similar studies have shown the expression of *BMP2*receptor in bovine antral follicles and its potential role in the development and functioning of ovarian follicles \[[@B21]\]. In support of these claims, we also detected this gene only in CCs suggesting its higher activity in CCs than in oocyte. *GSTA1*is highly expressed in steroidogenically active cells of bovine ovarian follicle and suggested to intervene in folliculogenesis and oocyte maturation \[[@B67]\] and steroid receptor cells are found only in CCs evidencing the involvement of CCs derived *GSTA1*in oocyte maturation. On the other hand, higher expression of *FST*and *INHBA*has been reported in cumulus oophorus that were obtained from in vivo produced COCs compared to these produced in vitro \[[@B68]\].

In order to validate the microarray data, specifically for those transcripts exclusively expressed in oocyte or CCs, we analyzed the expression of some selected genes using semi-quantitative PCR. A 2% agarose gel pictures showing transcripts that are specific to oocyte or CCs are shown in Figure [20](#F20){ref-type="fig"}. Previous studies have suggested that higher expression of *HAS2, PTX3, TNFAIP6, PTGS2, CD44, INHBA*and *BTC*in CCs can be used as molecular bio-markers to select quality embryo in women \[[@B40]\] and cow \[[@B48]\]. Higher expression of *PTX3, PTGS2, ADAMTS1, INHA*and *INHBA*was also reported in human CCs \[[@B42]\]. But, data that clearly demonstrate whether these transcripts are oocyte or CC specific or expressed in both is not available. Here, we show that none of *HAS2, PTX3, INHA, INHBA*and *CD44*are CC specific as they are expressed in both samples (supplemental tables S3 and S6, Figure [20](#F20){ref-type="fig"}).

Additionally, we report for the first time that POU class 5 homeobox 1 (*POU5F1*), interferon regulatory factor 6 (*IRF6*), sex determining region Y box2 (*SOX2*) and insulin like growth factor 2 binding protein 3 (*IGF2BP3*) are expressed only in oocytes while secreted protein, acidic, cysteine-rich (*SPARC*), glutamate pyruvate transaminase (*GPT*), ADAM metallopeptidase with thrombospondin type 1 (*ADAMTS1*) and heparanase (*HPSE*) are expressed only in CCs. Significantly higher expression of *POU5F1*has been reported in developmentally competent bovine oocytes and its loss of function has resulted in preimplantation lethality in mouse embryos as it is a central regulator of pluripotency \[[@B69]\]. Similarly, *SOX2*, which is expressed only in oocyte, is a developmental pluripotency marker and has been hypothesized as a regulator of *POU5F1*controlled genes \[[@B70]\] suggesting a possible synergetic effect of the two genes on oocyte maturation.

*IRF6*has been suggested as a key mediator of cellular proliferation and differentiation in mammary epithelial cells by facilitating entry into the G0 phase of the cell cycle \[[@B71]\]. It regulates cell proliferation and differentiation in different cell types and its higher expression in oocyte sample in the present study at both mRNA and protein levels (Figure [21](#F21){ref-type="fig"}) may show *IRF6*as a maternal candidate transcript that play a role in acquiring developmental competence. *ADAMTS1*is also expressed only in CCs but more abundantly at MII compared to at GV stage (Figure [20](#F20){ref-type="fig"}). Previously, increased expression of *ADAMTS1*protein has been reported in mouse GCs in response to preovulatory LH surge \[[@B72]\] where it targets Versican (*VCAN*), one of the proteins that cross link hyaluronic acid (HA) rich CCs matrix and contributes to oocyte maturation, ovulation and/or fertilization \[[@B73]\].

Transcripts specifically expressed in CCs also include SPARC, a multifunctional calcium-binding glycoprotein that modulates extracellular matrix interactions and influences cell-cell adhesion, migration and invasion in vitro and in vivo \[[@B74]\]. Although the role of SPARC in the biology of oocytes is not documented, the fact that it is expressed only CCs supports previous reports where it has been expressed only in the somatic cells of germarium and follicles during oogenesis \[[@B74]\].

The absence of CCs during in vitro maturation alters the gene expression profile of MII oocyte
----------------------------------------------------------------------------------------------

Despite the fact that we did not observe significant morphological differences between oocyte matured with or without the surrounding cumulus cells including the polar body extrusion, previous study in bovine \[[@B38]\] has shown that oocytes matured without the surrounding cumulus cells resulted in significantly reduced blastocysts rates compared to those matured in the presence of the surrounding cumulus cells. Therefore, we hypothesized that the absence of cumulus cells during maturation can affect the nuclear and molecular maturation of the resulting oocytes. Maternal gene expression is an important biological process in oocyte maturation. If the oocyte is to complete normal maturation processes, the underlying transcriptional mechanism must be robust. Interestingly, some of the genes that are under expressed due to removal of CCs before in vitro maturation have vital roles in gene expression. The most important one is RNA polymerase II, an enzyme that plays a significant role in gene transcription. Reduced expression of this gene due to removal of CCs before in vitro maturation means the expression of other genes is greatly affected and hence the developmental competence of such oocytes is compromised.

In vitro studies have shown that follicle stimulating hormone (FSH) dependent cyclic adenosine monophosphate (cAMP), the activator of MAPK signaling, is produced by CCs and diffuses to the oocyte via the gap junction \[[@B75],[@B76]\]. The activated MAPK in turn activates the components of MPF to initiate meiotic resumption \[[@B77]\] and simulate mos mRNA cytoplasmic polyadenylation during *Xenopus*\[[@B78],[@B79]\] and mouse \[[@B80]\] oocyte maturation. Low expression of molecules that play roles in biochemistry of oocyte maturation (*MAP3K2, MAP3K3*and *MAP4K14*) in OO-CCs samples may imply defects in the maturation process due to removal of CCs before maturation.

The capacity of the oocyte to metabolize glucose is positively correlated with its developmental potential and this depends on the presence of companion somatic cells \[[@B81],[@B82]\]. Glucose is a pivotal metabolite for COCs and is metabolized via various pathways. During oocyte maturation, a large proportion of total glucose is metabolized in the CCs via the glycolytic pathway to provide substrates such as pyruvate for energy production \[[@B83]\]. Consistent with this, some genes that are involved in carbohydrate metabolism are under expressed due to removal of CCs indicating defective energy metabolism in the groups cultured without CCs and hence poor developmental competence.

In general, removal of companion CCs at GV stage appeared to affect the gene expression of MII oocytes as a number of genes are over expressed in oocytes cultured with CCs relative to those cultured without. As explained above, some of these genes have been implicated to be involved in various biological processes that are pertinent to oocyte meiotic resumption and maturation supporting the notion that the presence of CCs during in vitro maturation is crucial for oocyte developmental competence. However, the majority of these over expressed genes are uncharacterized and/or their functions, particularly with regard to oocyte development and maturation, are poorly understood. Paradoxically, several previously identified and biologically important OSFs (*GDF9*, *BMP6*, *15*, *TGFBs*), zona pellucida proteins (*ZP2, 3, 4*), the components of MPF (*CDK1*and *Cyclin B1*) and others are missing from the list of genes over expressed in OO + CCs.

From these results, it can be argued that either these over expressed genes have functional redundancy with those missing genes or the expression of the latter is completed prior to CCs removal at GV stage and consequently they are detected as equally as those cultured without their CCs. One plausible explanation inline of the latter argument is the fact that bovine oocytes are transcriptionally active during folliculogenesis and transcriptional activity decreases at later stages of follicular development \[[@B84]\]. Additionally, our present microarray data analysis between GV and MII oocytes (data not shown) reveals that only *GDF9*and *CDK1*are slightly over expressed (fold change = 2.46) at MII relative to GV stage. Interestingly, while *BMP15*and *TGFB2*are over expressed at GV stage, *ZP2*, *4*and *Cyclin B1*are equally expressed between the two stages. Interestingly several genes have been found to be over expressed in MII stage relative to GV stage including *MPV17, ATP6V1D, TMEM127, NUDT14, UQCR, EXOSC6, MAPK10, CSNK1D, DBNL, FILIP1L, YIF1A and ARHGAP27*. Considering the transcriptional activity of bovine oocytes, the over-expression of transcripts at MII stage compared to the GV stage need further investigation in terms of transcriptional regulation of genes during oocyte maturation.

The absence of oocyte during in vitro maturation alters the gene expression profile of CCs
------------------------------------------------------------------------------------------

Notable interspecies differences exist whether OSFs are mandatory for FSH induced CCs expansion in vitro. In rat, the presence of OSFs are crucial for in vitro CCs expansion as oocytectomized complexes (CCs - OO) failed to expanded their cumulus oophorus \[[@B45]\]. In cattle and pig, CCs expansion doesn\'t depend on the presence of these factors as CCs - OO expanded as equally as the intact ones \[[@B46],[@B47]\]. In the present study the results of IPA showed that some of the genes under expressed due to removal of oocyte before in vitro maturation are classified into cellular growth and proliferation (*VEGFA*, *GADD45A*, *FOS*, *EGR1*, *HAS2*), cell cycle (*CCND2*, *CDCA8*, *CDK6*), and gene expression (*FOSB*, *TGFB2*, *ATF3*) functional groups (Figure [9](#F9){ref-type="fig"}). These genes are also mapped into a complex gene network that includes genes involved in cellular development such as *Cyclin D*, *HPSE*, *JUNB*and others (Figure [9](#F9){ref-type="fig"}). Some of these genes are not well characterized and their direct role in the biology of CC is poorly understood. However, results of previous studies in different species have shown that some of these genes are involved in cumulus expansion and oocyte maturation. For instance, genes from FOS family have been implicated as regulators of cell proliferation, differentiation and transformation and IGFPB proteins stimulate the growth promoting effects of *IGF1*which in turn is important for oocyte growth and maturation and granulosa cells proliferation \[[@B85]\].

Although a number of genes were differentially expressed between CCs that were cultured with or without their enclosed oocytes, it is not easy to conclude that removal of oocyte completely changes the expression of CCs genes at MII stage. For instance, except *HAS2*, the majority of CCs genes previously identified as molecular bio markers for developmental competence including *INHβA, EGFR, BTC, CD44, TNFAIP6, PTX3*and *PTGS2*\[[@B40],[@B48]\] were not differentially expressed between the two sample groups. From these results, we hypothesize that either these differentially expressed genes predict oocyte developmental competence better than the previously indentified ones or the transcription of these previously identified genes is completed earlier at GV stage before the ooplasm is removed and hence they are not differentially expression at MII stage. However, the assertion of both hypotheses requires further investigation.

The dynamics of CCs transcriptome during the transition of COCs from GV to MII stages is associated with functional changes
---------------------------------------------------------------------------------------------------------------------------

Massive transcript degradation during in vitro maturation of bovine \[[@B86]\], human \[[@B42],[@B59]\] and mouse \[[@B59]\] oocytes has been reported. Similarly, considerable shift of transcripts and associated functional changes were observed in CCs during the transition of COCs from GV to MII stage. For instance, while transcripts that are involved in cell cycle, DNA replication, metabolic process, steroid and cholesterol biosynthesis, signal transduction and regulation of catalytic activity are over expressed in CCs at GV stage, these involved in cell adhesion, protein metabolic process, regulation of cellular component organization and biogenesis and actin filament polymerization are over expressed in CCs at MII stage (Figure [13](#F13){ref-type="fig"}). The most interesting finding of this experiment is not only the change in the number of transcripts but also the identity of transcripts that are involved in a given GO term at the two developmental stages.

Cell cycle and DNA replication are the two successive events which play significant roles in meiotic process resulting in the formation of four haploid cells. The functioning of a cell depends upon its ability to extract and use chemical energy stored in organic molecules via metabolic pathways. On the other hand, MAPK activation in CCs rather than in oocytes exerts essential functions during mammalian oocyte meiotic resumption \[[@B66],[@B87]\] and steroids such as progesterone have been suggested to induce cAMP dependent MAPK signaling cascade leading to meiotic resumption \[[@B88]\]. Hence, over expression of transcripts that are involved in cell cycle, metabolic and steroid biosynthetic pathways in CCs at GV stage suggest that these pathways are more active in GV than in MII stage.

As the oocyte lacks gonadotropin receptors, it has been hypothesized that FSH exerts its effect via a positive meiosis factor (EGF) synthesized by CCs indirectly via signal transduction pathway that involves cAMP dependent MAPK to induce meiotic resumption \[[@B89]\]. From these findings, we propose that over expression of transcripts that are involved in signal transduction pathway at GV stage CCs relative to MII is an indication that this pathway is more active at the former than the latter.

Focal adhesions are large macromolecular assemblies through which both mechanical force and regulatory signals are transmitted \[[@B90]\]. They serve not only to anchor the cell, but also to carry signals, which inform the cell about the condition of the ECM and thus affect their behaviour \[[@B91]\]. In view of their increased expression at MII relative to their expression at GV stage, we propose that these genes are involved in one of the regulatory network that connects the oocyte to its companion CCs during in vitro maturation.

Actin filaments localize to specific regions within mammalian oocytes and their modelling including polymerization are important for oocyte maturation, fertilization and embryo development \[[@B76],[@B92],[@B93]\]. Interestingly, we found higher expression of transcripts that are involved in actin filament polymerization at MII than in GV CCs. Consistent with the notion that in vitro meiotic resumption in bovine oocytes is triggered by FSH \[[@B76],[@B93]\]; we observed higher expression of FSHR mRNA in GV CCs than in MII stage. Prior to in vitro meiotic resumption, FSH is received by CGCs via FSHR and this activates the release of cAMP and MAPK signaling pathways to initiate meiotic resumption \[[@B88]\].

CCs expansion is a key biological event for successful oocyte maturation, ovulation and fertility \[[@B40],[@B48],[@B94],[@B95]\]. *HAS2*is an important enzyme for the biosynthesis of HA to form stable matrix during CCs expansion \[[@B96]\]. The binding proteins of HA (*TNFAIP6*and *PTX3*) and its receptor protein (*CD44*) plays significant roles in attaining full CC expansion. *CD44*is a widely expressed cell adhesion molecule that binds the extracellular matrix component, HA in a tightly regulated manner \[[@B97]\]. The interaction between HA and *CD44*is the key molecular mechanism for the activation of signalling cascades that contribute to cell adhesion, proliferation, migration and differentiation \[[@B98],[@B99]\]. This interaction is also important for MAPK signalling pathway in oocyte and may promote meiotic resumption \[[@B100]\]. Oocytes can\'t attain cytoplasmic maturation when cultured in the absence of their companion CCs as they can\'t store sufficient mRNAs, proteins and transcription factors that are important for maturation process due to removal of the b-idirectional communication axis. The interaction between *HA*-*CD44*is critical for modification of this communication axis during CCs expansion \[[@B101]\] and relatively higher expression of these molecules in cultured CCs is consistent with the notion that *HA*-*CD44*interactive effect is vital for oocyte maturation \[[@B100]\].

The majority of genes differentially expressed between different oocyte and CCs samples are poorly characterized and their roles in the biology of bovine oocyte are not known. Moreover, due to the dynamic nature of gene expression in different species, tissues and follicular stages, what have been reported so far in other organisms may not necessarily hold true for bovine oocytes and CCs. Therefore, we recommend detailed gene by gene study to unveil specific roles of these genes in the biology of bovine COCs.

Conclusion
==========

In conclusion, this study has generated large scale gene expression data from different oocyte and CCs samples that would provide insights into gene functions and interactions within and across different pathways that are involved in the maturation of bovine oocytes. Moreover, the presence or absence of oocyte and CC factors during bovine oocyte maturation can have a profound effect on transcript abundance in each cell types, showing the molecular cross-talk between oocytes and their corresponding CCs.
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